Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

22 May, 2017, 11:00 ET Starting Statins in Older Patients Not Effective as Preventive Care

Statins are increasingly prescribed to geriatric patients to stave off premature death from heart disease despite a lack of evidence that this...


22 May, 2017, 11:00 ET Symic Bio Secures $30 Million Series B Financing and Provides SB-030 Program Update

Symic Bio, a biopharmaceutical company developing novel matrix regulator therapeutics, today announced the successful completion of a $30 million...


22 May, 2017, 09:15 ET Big Data Yields Big Insights for Treatment of Central Sleep Apnea

According to a new ResMed-sponsored (NYSE:RMD) study, people with treatment-emergent central sleep apnea (CSA) have a significantly greater risk of...


22 May, 2017, 09:15 ET CollPlant Extends its European Distribution Network With Signing of New Distribution Agreement in Turkey for Vergenix®FG Wound Treatment

CollPlant (TASE: CLPT), a regenerative medicine company utilizing its proprietary plant-based rhCollagen (recombinant human "rhCollagen")...


22 May, 2017, 09:00 ET ViaCyte Receives IND Allowance from FDA and Clearance from Health Canada to Commence International Clinical Trial of PEC-Direct Cell Therapy for High-Risk Type 1 Diabetes

ViaCyte, Inc., a privately-held leading regenerative medicine company, announced today that the U.S. Food and Drug Administration (FDA) has allowed...


22 May, 2017, 09:00 ET JDRF and ViaCyte Announce Support for Development of PEC-Direct Cell Replacement Therapy for Type 1 Diabetes

ViaCyte, Inc., a privately-held leading regenerative medicine company, and JDRF, the leading global organization funding type 1 diabetes research,...


22 May, 2017, 09:00 ET Viriom to Present Results of Pre-Clinical Pharmacokinetic Studies with Elsulfavirine and VM1500A Long Acting Injectable Formulations at the International AIDS Society (IAS) Conference 2017

Viriom Inc. today announced that the data from pre-clinical studies of Elsulfavirine/VM1500A Long Acting Injectable Formulations will be presented...


22 May, 2017, 09:00 ET Philips-sponsored clinical study demonstrates significant breakthrough for COPD treatment

Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT)...


22 May, 2017, 08:35 ET New Website Highlights an Unexpected Effect of a Natural Treatment on HPV Clearance in Infected Individuals

Lilac Corp, the company that sells the natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of a new website. The website...


22 May, 2017, 08:26 ET Longeveron to receive Grant from the Maryland Stem Cell Research Fund

Longeveron announced receiving a $750,000 grant from the Maryland Stem Cell Research Fund (MSCRF) to continue groundbreaking stem cell research....


22 May, 2017, 08:16 ET Xynomic Pharma and UCSF Entered Strategic Partnership in Conducting a Phase 2/3 Trial of Abexinostat against Renal Cell Carcinoma

Xynomic Pharma, a clinical stage US oncology drug R&D company, today announced that it has entered into a strategic partnership with the...


22 May, 2017, 07:30 ET NewStem Introduces Novel Technology for Predicting Resistance to Chemotherapies

NewStem, introduces a novel technology for predicting resistance to chemotherapy treatments. The Company is developing a diagnostic kit based on...


22 May, 2017, 07:05 ET PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology

PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and RXi Pharmaceuticals (NASDAQ: RXII) a biotechnology company focused on...


22 May, 2017, 07:04 ET BrainStorm to Present at Cell & Gene Exchange Conference in Washington DC

BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced...


22 May, 2017, 07:00 ET NuVasive Announces Educational Initiatives In Support Of Spine's Fastest Growing Spinal Deformity Portfolio

NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive,...


22 May, 2017, 07:00 ET BioLineRx Announces Regulatory Submission for Phase 1b Trial of BL-8040 in Combination with Atezolizumab in AML

BioLineRx Ltd. (NASDAQ: BLRX, TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today the...


22 May, 2017, 03:00 ET BONESUPPORT Announces First Patient Enrolled in FORTIFY Trial With CERAMENT G, a Novel Injectable, Antibiotic-eluting Bone Graft Substitute

BONESUPPORT AB, an emerging leader in innovative injectable bioceramic bone substitute products to treat bone voids caused by trauma, infection,...


22 May, 2017, 02:42 ET Attendee List Released for Biobanking 2017

SMi Group have released an attendee list featuring a global audience of Europe's leading biorepositories, regulatory bodies and scientific experts...


21 May, 2017, 18:01 ET Amgen And UCB Announce Top-Line Phase 3 Data From Active-Comparator Study Of EVENITY™ (Romosozumab) In Postmenopausal Women With Osteoporosis

Amgen (NASDAQ:AMGN) and UCB (Euronext Brussels: UCB) today announced that the EVENITY™* (romosozumab) ARCH study met both primary endpoints and the...


21 May, 2017, 10:04 ET Clinical Trial Published in JAMA Offers New Hope for COPD Patients

People suffering from chronic obstructive pulmonary disease (COPD) – the third leading cause of death in the United States – may see their lives...